header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
The present invention relates to a method for treating a subject suffering from a cancer comprising a step of administering said subject with a […]
Inventors have generated two human anti-cath-D scFv fragments cloned in the human IgG1 format (F1 and E2) that efficiently bind to human and […]
Inventors analyzed the prognostic value of tumor and stromal-derived SPARC in a large series that included 148 non-metastatic TNBC patients with a […]
Investigating the impact of Tau protein expression in cancer cell lines, Inventors have demonstrated that the Tau expression is associated with an […]
The present invention relates to the prediction of the survival time of a patient suffering from a cancer. The inventors identified in blood from […]
The present invention relates to the field of cancer treatment. In this study, the inventors sought to investigate whether this antiproliferative […]
The present invention relates to a method for treating a subject suffering from a cancer comprising […]
Inventors analyzed the prognostic value of tumor and stromal-derived SPARC in a large series that […]
Investigating the impact of Tau protein expression in cancer cell lines, Inventors have demonstrated […]
The present invention relates to the prediction of the survival time of a patient suffering from a […]
Inventors have generated two human anti-cath-D scFv fragments cloned in the human IgG1 format […]
The present invention relates to the field of cancer treatment. In this study, the inventors sought […]
Research tool licensing team
researchtools@inserm-transfert.fr
User accounts are momentarily unavailable
The Inserm Transfert website is currently undergoing maintenance. It will be available again in a few hours.